Abstract
Objective We sought to assess the effect of allergen immunotherapy (AIT) with Alutard? SQ in patients with allergic asthma and rhinitis. Methods Designed the questionnaire and surveyed 39 patients with allergic asthma and rhinitis accepting AIT with Alutard? SQ allergen extract so that we can know their situation before and after accepting AIT. We used levels of asthma control and Asthma Control Test(ACT)to evaluate their levels of asthma control, and used Rhinitis condition score (RCT) to evaluated their rhinitis control. Results 39 subjects completed the survey, and the results showed: AIT resulted in a significant improvement in levels of asthma control( Z = - 7. 235, P <0. 05), ACT (t =16.533, P <0. 05), RCT (t =16.650, P <0. 05) and mood(x2= 34. 873, P <0. 05). Conclusions AIT with Alutard? SQ significantly improved symptoms of the patients with allergic asthma and rhinitis. Key words: Allergen immunotherapy; Bronchial asthma; Allergic rhinitis; Alutard? SQ; Questionnaire
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
